<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD) face an increased lifetime risk of developing <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Independent factors associated with increased risk include long disease duration, extensive colonic involvement, young age at <z:hpo ids='HP_0003674'>onset</z:hpo> of IBD, severity of <z:mp ids='MP_0001845'>inflammation</z:mp>, primary sclerosing <z:mp ids='MP_0003254'>cholangitis</z:mp>, backwash <z:mp ids='MP_0009482'>ileitis</z:mp>, and a family history of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, thus emphasising the role of <z:mp ids='MP_0001858'>intestinal inflammation</z:mp> as an underlying mechanism </plain></SENT>
<SENT sid="2" pm="."><plain>This notion is also supported by the demonstration that the use of certain drugs used to attenuate the ongoing mucosal <z:mp ids='MP_0001845'>inflammation</z:mp>, such as <z:chebi fb="0" ids="6775">mesalazine</z:chebi>, seems to associate with a reduced incidence of <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>In the last decade, work from many laboratories has contributed to delineate the mechanisms by which <z:chebi fb="0" ids="6775">mesalazine</z:chebi> alters <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell behaviour </plain></SENT>
<SENT sid="4" pm="."><plain>In this paper, we review the available experimental data supporting the ability of <z:chebi fb="0" ids="6775">mesalazine</z:chebi> and its derivatives to interfere with intracellular signals involved in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell growth </plain></SENT>
</text></document>